These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19796441)

  • 1. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Parmenter BA; Testa SM; Schretlen DJ; Weinstock-Guttman B; Benedict RH
    J Int Neuropsychol Soc; 2010 Jan; 16(1):6-16. PubMed ID: 19796441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression-based norms improve the sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
    Smerbeck AM; Parrish J; Yeh EA; Weinstock-Guttman B; Hoogs M; Serafin D; Krupp L; Benedict RH
    Clin Neuropsychol; 2012; 26(6):985-1002. PubMed ID: 22849345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
    Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Landi D; Palmieri MG; Moffa F; Rinaldi P; Vernieri F; Filippi MM
    Neurol Sci; 2016 Aug; 37(8):1261-70. PubMed ID: 27095052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the California Verbal Learning Test-II in multiple sclerosis.
    Stegen S; Stepanov I; Cookfair D; Schwartz E; Hojnacki D; Weinstock-Guttman B; Benedict RH
    Clin Neuropsychol; 2010 Feb; 24(2):189-202. PubMed ID: 19953426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisaccade performance in patients with multiple sclerosis.
    Fielding J; Kilpatrick T; Millist L; White O
    Cortex; 2009; 45(7):900-3. PubMed ID: 19327763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal neuropsychological assessment of MS patients: a consensus approach.
    Benedict RH; Fischer JS; Archibald CJ; Arnett PA; Beatty WW; Bobholz J; Chelune GJ; Fisk JD; Langdon DW; Caruso L; Foley F; LaRocca NG; Vowels L; Weinstein A; DeLuca J; Rao SM; Munschauer F
    Clin Neuropsychol; 2002 Aug; 16(3):381-97. PubMed ID: 12607150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging.
    Fink F; Eling P; Rischkau E; Beyer N; Tomandl B; Klein J; Hildebrandt H
    Mult Scler; 2010 Mar; 16(3):332-41. PubMed ID: 20150400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metamemory and tested cognitive functioning in multiple sclerosis.
    Randolph JJ; Arnett PA; Higginson CI
    Clin Neuropsychol; 2001 Aug; 15(3):357-68. PubMed ID: 11778774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of cognitive impairment in the expanded disability status scale of 215 patients with multiple sclerosis.
    Brissart H; Sauvée M; Latarche C; Dillier C; Debouverie M
    Eur Neurol; 2010; 64(6):345-50. PubMed ID: 21071951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.
    Walker LAS; Marino D; Berard JA; Feinstein A; Morrow SA; Cousineau D
    Can J Neurol Sci; 2017 Sep; 44(5):547-555. PubMed ID: 28683843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.